A Novel Non Invasive Brain Stimulation Based Treatment for Chronic Low Back Pain (CLBP)

NCT02393391 | Unknown Phase 2

• 1 other identifier: TASMC-14-SB-600-CTIL
• Study Type: interventional
• Target: 80
• Locations: 0 countries
• Sites: N/A

Brief Summary

Neuropathic pain results from damage to or dysfunction of the peripheral or central nervous system, rather than stimulation of pain receptors. Diagnosis is suggested by pain out of proportion to tissue injury, dysesthesia (eg, burning, tingling), and signs of nerve injury detected during neurologic examination. Although neuropathic pain responds to opioids, treatment is often with adjuvant drugs (eg, antidepressants, anticonvulsants, baclofen, topical drugs). Neuropathic pain (e.g. phantom limb pain, CRPS, postherpetic neuralgia, postsurgical pain syndromes, CLBP etc.) remains a challenging condition to treat because it is commonly refractory to classical pharmacological and to surgical treatment approaches. Chronic low back pain (CLBP) is a widespread and costly problem for which few interventions are effective. An increased focus on the study of the nervous system and its involvement in pain disorders has documented complex neuronal activity and structural changes at a peripheral, as well as at spinal cord and cortical levels indicating a neuropathic element in CLBP. Accumulated evidence suggests that neuropathic pain in general and CLBP specifically might be associated to brain cortical plastic changes. Thus an ideal rehabilitative approach should aim to reverse them. In line with this idea, the investigators suggest an innovative noninvasive intervention aimed at alleviating neuropathic pain. New rehabilitative approaches have been proposed to try and reverse this cortical reorganization. Results of several studies have shown that motor cortex stimulation with epidural electrodes or repetitive transcranial magnetic stimulation (rTMS) or transcranial direct stimulation (tDCS) are effective in reducing pain in patients with central pain refractory to treatment. Transcranial direct current stimulation (tDCS) is an easily applied and safe technique by which brain activity can be modulated noninvasively and can decrease pain in patients with refractory central pain. The investigators hypothesized that focal-tDCS treatment personally customized to each patients basal neuronal network properties would result in both acute and long term pain relief for neuropathic pain patients.

Conditions

Chronic Low Back Pain

Outcome Measures

Primary Outcomes (1)

• Evaluation of treatment efficacy (evaluated by pain level and sleep quality questionnaire)

  Efficacy of the treatment will be evaluated by pain level and sleep quality questionnaire

  one year

Study Arms (2)

NIBS tDCS/tACS stimulation

ACTIVE COMPARATOR

Each patient will undergo initial diagnosis with NIBS algorithm utilizing EEG measurements combined with TMS. Initial diagnosis will last 10 minutes in which EEG measurement will be recorded 5 minutes and then in combination with TMS for another 5 minutes with no more than 500 TMS stimuli applied to cortex at low frequency of up to 5Hz. EEG recording will be analyzed by NIBS algorithm which will propose a course of treatment with the following limitations: stimulation of 2mA (32, 33) current after 30 seconds ramp up of 0.1mA increments, 20 min for each session, twice a week

Device: Neuroelectrics STARSTIM

inactive electrodes

PLACEBO COMPARATOR

diagnosis and monitoring will be performed as in active treatment, but during treatment anodal/cathodal/alternate stimulation will begin and automatically stop after 30 seconds leaving subject with an inactive electrodes in place for the remainder of treatment duration

Device: Neuroelectrics STARSTIM

Interventions

Neuroelectrics STARSTIM DEVICE

NIBS tDCS/tACS stimulation; inactive electrodes

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• age 18 to 70
• CLBP as defined by the European guidelines

You may not qualify if:

• Acute low back pain (duration of less than 6 months
• Neurological illness causing structural brain damage (e.g. Stroke, TIA)
• Psychiatric disease other than mood disorders
• Current chronic use of medications with pro-epileptic properties
• Known alcohol dependency
• Use of alcohol within the previous 24 hours
• History of loss of consciousness
• Epilepsy or epilepsy in a first degree relative
• Medical implants
• Pregnancy
• Illicit drug use or within the previous month

Sponsors & Collaborators

• Tel-Aviv Sourasky Medical Center: lead
• NIBS NeuroScience Technologies: collaborator

Central Study Contacts

Silviu Brill, Dr.

CONTACT

97236974581; paincenter@tlvmc.gov.il

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 8, 2015
• First Posted: March 19, 2015
• Study Start: May 1, 2015
• Primary Completion: May 1, 2015
• Last Updated: March 19, 2015

Record last verified: 2015-03